Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?
We now have a pretty good idea how much COVID-19 vaccines will cost Uncle Sam. Last week, The U.S. government announced a deal with Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) to buy 100 million doses of the two partners' lead coronavirus vaccine candidate for $1.95 billion. That translates to a price tag of $19.50 per dose.
But Moderna (NASDAQ: MRNA) is considering pricing its COVID-19 vaccine at more than 50% higher than Pfizer's price tag for its vaccine, according to a report in the Financial Times. Will Moderna be able to get away with such a higher price?
Image source: Getty Images.
Source Fool.com